Ultrasonographic Prognostic Scale of Periventricular Hemorrhagic Infarction
NCT ID: NCT05918016
Last Updated: 2023-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
360 participants
OBSERVATIONAL
2017-01-31
2025-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Intraventricular Hemorrhage Using Echocardiography and Near Infrared Spectroscopy
NCT05708105
Research a New Predictive Marker of Intraventricular Hemorrhage in Very Preterm Infants
NCT02400853
A Prospective Longitudinal Study to Identify Biomarkers in Children With Hemangiomas
NCT01598116
Research on Prevention, Early Detection, and Clinical Evaluation of Intracranial Hemorrhage in Preterm Infants
NCT07157020
Early Neurological Outcome in Newborns With Mild Encephalopathy:a Regional Network
NCT05785481
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Routine cranial ultrasounds
we will use the routine cranial ultrasounds
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Genetic syndrome
* Metabolic disorders
* Chromosomal abnormality
* None cranial ultrasound
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Manuel Sanchez Luna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Manuel Sanchez Luna
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gregorio Marañon Hospital
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Neuro.Neo.1.IVH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.